State-of-the-Art Hepatitis Research in 2022
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Hepatitis Virus Vaccines".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 2022
Special Issue Editor
Interests: hepatitis viruses (A, B, C, D, and E); experimental system; host immune responses; vaccines; pathogenesis
Special Issue Information
Dear Colleagues,
In recent decades, numerous studies focused on the virology, epidemiology, immunology, genetics, molecular biology, natural history, pathogenesis, current drug treatment, and new drug development in hepatitis research have strengthened our knowledge in this field. Such research provides the chance to identify and develop vaccines and treatments or cure viral hepatitis infections. Therefore, we welcome contributions to this Special Issue of Viruses, “State-of-the-Art Hepatitis Research in 2022”. The aim is to provide comprehensive information on all aspects of hepatitis research. Contributions to this Special Issue will advance our knowledge of hepatitis induced by virus infections and provide a better understanding of this serious human pathogen. This Special Issue will bring together original research papers and review manuscripts on hepatitis research with a focus on acute/chronic viral replication, pathogenesis, immune responses, vaccine development, hepatic disease, and antiviral treatments in viral hepatitis research.
Dr. Youkyung Choi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute infection
- chronic infection
- virus replication
- pathogenesis
- immune responses
- vaccine development
- antiviral treatment
- in vitro and in vivo experimental infection systems
- host factors and biomarkers in viral hepatitis infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
